Fluicell AB (ST:FLUI) — Market Cap & Net Worth
Market Cap & Net Worth: Fluicell AB (FLUI)
Fluicell AB (ST:FLUI) has a market capitalization of $4.51 Million (Skr41.90 Million) as of August 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #28743 globally and #651 in its home market, demonstrating a -2.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fluicell AB's stock price Skr30.50 by its total outstanding shares 1373703 (1.37 Million). See FLUI capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Fluicell AB Market Cap History: 2018 to 2026
Fluicell AB's market capitalization history from 2018 to 2026. Data shows growth from $1.02 Million to $4.51 Million (8.75% CAGR).
Fluicell AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fluicell AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
Fluicell AB's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.02 Million | $1.23 Million | -$14.70 Million | 0.83x | N/A |
| 2019 | $1.29 Million | $2.49 Million | -$18.64 Million | 0.52x | N/A |
| 2020 | $3.02 Million | $4.63 Million | -$18.15 Million | 0.65x | N/A |
| 2021 | $2.97 Million | $2.60 Million | -$21.72 Million | 1.14x | N/A |
| 2022 | $384.36K | $3.25 Million | -$21.49 Million | 0.12x | N/A |
| 2023 | $93.43K | $3.34 Million | -$26.55 Million | 0.03x | N/A |
| 2024 | $6.06K | $1.86 Million | -$15.51 Million | 0.00x | N/A |
| 2025 | $1.48 Million | $6.00 Million | -$8.33 Million | 0.25x | N/A |
Competitor Companies of FLUI by Market Capitalization
Companies near Fluicell AB in the global market cap rankings as of August 5, 2026.
Key companies related to Fluicell AB by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #423 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #564 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $470.72 |
| #423 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $759.24 |
| #541 | Argen-X | BR:ARGX | $49.55 Billion | €722.20 |
| #564 | UCB SA | BR:UCB | $47.34 Billion | €221.40 |
Fluicell AB Historical Marketcap From 2018 to 2026
Between 2018 and today, Fluicell AB's market cap moved from $1.02 Million to $ 4.51 Million, with a yearly change of 8.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr4.51 Million | +205.00% |
| 2025 | Skr1.48 Million | +24290.24% |
| 2024 | Skr6.06K | -93.51% |
| 2023 | Skr93.43K | -75.69% |
| 2022 | Skr384.36K | -87.06% |
| 2021 | Skr2.97 Million | -1.47% |
| 2020 | Skr3.02 Million | +133.94% |
| 2019 | Skr1.29 Million | +26.40% |
| 2018 | Skr1.02 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Fluicell AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.51 Million USD |
| MoneyControl | $4.51 Million USD |
| MarketWatch | $4.51 Million USD |
| marketcap.company | $4.51 Million USD |
| Reuters | $4.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fluicell AB
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve sys… Read more